|End-of-day quote - 03/02|
Aft Pharmaceuticals : Posts Decline in Profit, Rise in Revenue for Six Months Ended September; Shares Down 5%
|11/18/2020 | 06:43pm|
Revenue for the half-year rose year over year to NZ$48.8 million from NZ$46.9 million.
For fiscal 2021, the company expects operating profit to range from NZ$14 million to NZ$18 million, a 23% to 58% growth over FY20. The company said it will review its dividend policy in FY22 when debt returns to a satisfactory level.
Shares of the company were down nearly 5% in recent trading.
Price (AUD): $4.86, Change: $-0.24, Percent Change: -4.71%